Age-related medicine

John Wahlich*, Mine Orlu, Alpana Mair, Sven Stegemann, Diana Van Riet-Nales

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk–benefit ratio of a medicine changes as an individual ages. The way in which regulatory authorities are encouraging the development of age-appropriate medicines was highlighted. Examples were provided of the difficulties faced by the older population with some medicinal products and suggestions given as to how the pharmaceutical scientist can build the requirements of the older population into their development of new medicines, as well as improvements to existing ones.

Original languageEnglish
Article number172
Issue number4
Publication statusPublished - 1 Apr 2019


  • Ageing
  • Multiple morbidities
  • Pharmaceutical sciences
  • Polypharmacy
  • Product development

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this